[{"indications": "Indications\u00a0nausea and vomiting caused by cytotoxic chemotherapy, unresponsive\r\nto conventional antiemetics (under close observation, preferably in\r\nhospital setting)", "name": "NABILONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.6 Drugs used in nausea and vertigo", "Cannabinoid", "NABILONE"], "cautions": "Cautions\u00a0history of psychiatric disorder; elderly; hypertension; heart disease; adverse\r\neffects on mental state can persist for 48\u201372 hours after stoppingDriving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol enhanced", "side-effects": "Side-effects\u00a0drowsiness, vertigo, euphoria, dry mouth, ataxia,\r\nvisual disturbance, concentration difficulties, sleep disturbance,\r\ndysphoria, hypotension, headache and nausea; also confusion, disorientation,\r\nhallucinations, psychosis, depression, decreased coordination, tremors,\r\ntachycardia, decreased appetite, and abdominal painBehavioural effects\u00a0Patients should\r\nbe made aware of possible changes of mood and other adverse behavioural\r\neffects", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3449.htm", "doses": ["Initially 1\u00a0mg twice daily, increased if necessary to\r\n2\u00a0mg twice daily, throughout each cycle of cytotoxic therapy and,\r\nif necessary, for 48 hours after the last dose of each cycle; max.\r\n6\u00a0mg daily given in 3 divided doses. The first dose should be taken\r\nthe night before initiation of cytotoxic treatment and the second\r\ndose 1\u20133 hours before the first dose of cytotoxic drug; adolescent and child under 18 years consult local treatment protocol [unlicensed use]"], "pregnancy": "Pregnancy\u00a0avoid unless essential"}]